➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Boehringer Ingelheim
Medtronic
McKinsey
Johnson and Johnson

Last Updated: June 14, 2021

DrugPatentWatch Database Preview

HIKMA Company Profile


Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for HIKMA, and when can generic versions of HIKMA drugs launch?

HIKMA has three hundred and fifty-nine approved drugs.

There are five US patents protecting HIKMA drugs. There are three tentative approvals on HIKMA drugs.

Drugs and US Patents for HIKMA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma METHADONE HYDROCHLORIDE methadone hydrochloride CONCENTRATE;ORAL 040180-001 Apr 30, 1998 AA RX No No   Get Started Free   Get Started Free
Hikma TETRACYCLINE HYDROCHLORIDE tetracycline hydrochloride CAPSULE;ORAL 060768-001 Approved Prior to Jan 1, 1982 DISCN No No   Get Started Free   Get Started Free
Hikma IMIPRAMINE PAMOATE imipramine pamoate CAPSULE;ORAL 091099-004 Apr 16, 2010 AB RX No No   Get Started Free   Get Started Free
Hikma Intl Pharms MITIGARE colchicine CAPSULE;ORAL 204820-001 Sep 26, 2014 RX Yes Yes 9,399,036   Get Started Free   Get Started Free
Hikma Pharms ZALEPLON zaleplon CAPSULE;ORAL 078147-002 Nov 25, 2008 DISCN No No   Get Started Free   Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for HIKMA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Hikma ATIVAN lorazepam INJECTABLE;INJECTION 018140-001 Approved Prior to Jan 1, 1982 4,017,616   Get Started Free
Hikma ATIVAN lorazepam INJECTABLE;INJECTION 018140-002 Approved Prior to Jan 1, 1982 4,017,616   Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for HIKMA drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Capsules 0.6 mg ➤ Subscribe 2016-06-10
➤ Subscribe Injection 1 mg/mL, 50 mL vials ➤ Subscribe 2011-12-16
➤ Subscribe Tablets 1 mg ➤ Subscribe 2009-08-14
➤ Subscribe Injection 100 mg/mL, 2.5 mL vials ➤ Subscribe 2007-09-24
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
Colorcon
Medtronic
Baxter
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.